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Purpose: To describe the extent of undispensed 
prescriptions as a result of drug unavailability in a tertiary 
health facility in Saudi Arabia 
Methods: This study was conducted prospectively in a 
large teaching hospital over a 6 months period from May 
to October of 2005 and tracked 14 commonly prescribed 
drugs. The bimonthly drug requisition forms and the 
amount supplied by medical supply department (MSD) 
were collected and reviewed.  
Results: Total number of prescriptions issued for the 
drugs under examination was 29113.  26551 prescriptions 
were dispensed while the remaining 2562 (9%) were 
undispensed due to drug unavailability. The difference 
between quantity of drugs requested by the pharmacy and 
quantity issued from MSD was 47-52%.  
Conclusion: Mismatch between drug demand and supply 
in the facility studied is the main cause of shortage. 
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The shortages of drug products often lead to 
delayed or cancelled procedures, prolonged 
hospital stay, increase cost of therapy, and can 
impact negatively on patient care [1,2]. As a 
result, pharmacists spend valuable time 
communicating with manufacturers and suppliers 
during drug shortages.  Cases have been reported 
of drug related problems where alternative drug 
therapies are substituted for unavailable products 
or replacement therapies. To minimize adverse 
effects on patient care and health-system costs, 
guidelines on managing drug product shortages in 
hospitals and health systems have been developed 
to help in preparing and planning for drug 
product supply [1].  
The causes of drug shortage can be categorized 
either as demand or supply reasons [1-4]. 
Reasons associated with demand include changes 
in drug use pattern such as indication expansions, 
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increased number of patients, and changes in 
dosage recommendation. However, manufac-
turing difficulties or natural disasters that affect 
production, reductions in the supply of raw 
materials, voluntary recalls, and manufacturer 
business decisions are associated with supply.  
Several published studies have been reported on 
frequency of drug products shortages attributable 
to drug manufacturers. A survey involving 370 
pharmacy directors at US found that 49% of the 
respondents had experienced a shortage of seven 
of the nine drugs presented to them
 
[5]. Another 
US based study that examined drug shortages 
prospectively at one hospital identified 108 drug 
product shortages from January 2001 through 
June 2002 [6]. In Germany 191 supply shortages 
of drugs were identified in a 2 years study period 
[7]. A survey of Canadian community 
pharmacists indicated that 63% of the 
pharmacists experienced a shortage during one 





The aim of this study was to describe the extent 
of undispensed prescriptions due to drug 
unavailability for non-manufacturer related 
reasons at a large teaching hospital. The main 
outcome measure was proportion of undispensed 




The study was conducted prospectively over a 6 
months period from May 1
st
 to October 31
st
 of 
2005 at the outpatient pharmacy of a tertiary 
referral teaching hospital in Riyadh, Saudi 
Arabia. Medications in this hospital are free at the 
point of care. The process of purchase of 
pharmaceuticals and medical supplies is mainly 
through the Cooperation Council for the Arab 
States of the Gulf (GCC) Group Purchasing 
Program [9]; direct purchases and extra drug 
stocks may be requested depending upon the need 
during the year. The MSD inventory strategy is to 
reduce stockholding to save on storage costs and 
to tie up less money in drugs sitting on shelves 
which is called Just-in-time inventory model [1]. 
The pharmacy department requests for drugs 
from MSD bimonthly. 
Due to the sheer volume of prescriptions issued 
weekly at the study site and the costs involved in 
processing large amount of data, the study 
focused on 14 commonly prescribed drugs.  For 
each drug, the number of prescriptions dispensed 
and prescriptions returned to patients [not 
dispensed] due to drug unavailability were 
identified. The following information was 
extracted from each undispensed prescription: 
drug name, dose, frequency, duration, patient’s 
hospital number, and date of issuing the 
prescription.  At the end of the study period 
patients’ hospital number were fed to the 
computer Hospital Information System (HIS) to 
follow up the undispensed prescription in order to 
identify date of dispensing and quantity 
dispensed.  
 
The bimonthly drug requisition forms and the 
amount supplied by Medical Supply Department 
(MSD) were collected and reviewed. Quantity of 
drugs available on the shelf throughout the period 
was estimated to identify the quantity of the 





The data collected were entered into Microsoft 
Excel spreadsheet (Microsoft Corporation, USA). 
Descriptive statistics were used in the 




The total number of prescriptions issued for the 
14 drugs under examination was 29113. Of these, 
26551 prescriptions were dispensed while the 
others (9%) were undispensed due to drug 
unavailability at the study site. During the study 
period there was no reasons given by the drug 
manufacturers that could explain such 
unavailability. As shown in Table 1 the rate of 
undispensed prescriptions was more frequent in 
May, June and July. Simvastatin top the list of the 
undispensed prescriptions (Table2). 
 
The quantity of tablets requested by the out-
patient pharmacy was compared to quantity 
supplied by the MSD. The MSD supplied only 
48%,  50%,  51%,  47%,  and  55%  of  quantity  
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Table 1: Dispensed and undispensed prescriptions 
  
Month  Dispensed Undispensed  Total  
May 5638 1601 (22) 7239 
June 4798 542 (10) 5340 
July 4388 151 (3) 4539 
August 4568 54 (1) 4622 
September 4647 103 (2) 4750 
October 2512 117 (4) 2629 
Total 26551 2568 (9) 29119 
 
requested in May, June, July, August, and 




This study has identified a high level of 
unavailability of drugs in the facility studied. In 
this prospective study, up to 9% of issued 
prescriptions were undispensed due to drugs 
unavailability during the 6 months period.  The 
proportion of undispensed drugs was accounted 
for by the shortage of supply to the pharmacy 
department. In the facility studied, the MSD 
utilizes information such as the formulary 
indications for each medication and the number 
of patients going to use the medication from the 
various specialized clinics to estimate quantity to 
be purchased.  Different reasons can be advanced 
for the demand and supply mismatch. First, there 
is the possibility that some prescriptions were not 
issued by the expected specialized clinics. 
Second, some patients were seen in more than 
one clinic and received different prescriptions for 
the same medication. This was evidence in our 
data when we compared the patients’ hospital 
numbers, names of medication, and issuing 
clinics (data not shown). A drug inventory 
control system seamlessly connected with the 
physician order-entry system could counter such 
duplication [10]. Automation in the drug 
distribution processes is also helpful in making 
inventory functions faster and more efficient [11]. 
The adaptation of modern inventory techniques 
provides the pharmacist with a practical basis for 
inventory management [12]. Third, the MSD also 
estimated the quantity of stockholdings based on 
factors such as the pharmacy previous orderings 
plus increment of up to 20% which often does not 
account for expansion in drugs indications or 
increasing number of eligible patients over time. 
To prevent this problem, the MSD must take into 
account that when clinical data support a new use 
of a product the prescribers may want to try it.  At 
the same time a formal education process is 
necessary for prescribers to attenuate the 
increased cost associated with prescribing outside 
the  specified  formulary  indication  and  how  it  
 
Table 2: Frequency of un-dispensed drugs 
 
Drug name   Dispensed Undispensed  Percentage  
undispensed 
Simvastatin  6866 824 32% 
Alendronate 1069 781 30% 
Atorvastatin  3113 680 27% 
Rosiglitazone 730 81 3% 
PPI 2951 73 3% 
Tamsulosin 1135 60 2% 
Citalopram 186 27 1% 
Amlodipine  4328 22 1% 
Bisoprolol  3590 6 0% 
Paroxetine 973 3 0% 
Topiramate  473 3 0% 
Mycophenolate 349 2 0% 
Fluoxetine 704 0 0% 
Vigabtrine  84 0 0% 
         Total 26551 2562 100% 
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heightened demands for a product that the 
pharmacy may not be able to meet.   
 
Certain practices within the dispensing process 
may further explain the unexpected increase in 
demands on drugs.  For example, to provide for 
the need of patients going for holidays 
pharmacists tend to dispense medications in 
quantity sufficient for longer period of time.  This 
may explain the timing of shortages in our study, 
over May to July, which coincides with the 
school holidays.  
 
The results of this study are limited by some 
factors. First. our study examined 14 drugs in 
specific period at a single study site and cannot 
be generalized. Second, no attempt was made to 
investigate the approaches patients adopt in 
response to drug unavailability even though there 
are indications that some of the prescriptions end 
up being dispensed at a retail pharmacy, which 




A reasonable proportion of drugs prescribed for 
patients at the facility studied are undispensed 
due to unavailability of drugs. This is due to 
mismatch between pharmacy demand and supply 
Adequate inventory management is needed in all 
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